FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application from Apotex Corp. for ipratropium bromide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

SUPPL AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)